Indeed, insulin resistance was resolved, showing that the elevated fasting plasma glucose levels (Figure 6G) and the body mass (Supplemental Figure 5A) by the HFD+VDD mice were improved through DEFA5 treatment. The gene discussed is DEFA5; the disease is Insulin resistance.